英: intravascular constant infusion

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 周術期に使用する輸液用器具intravenous infusion devices for perioperative use [show details]
…Intravenous (IV) infusion pumps are used to administer medications and fluids to all patients in perioperative and critical care settings. This topic will review the technology and use of IV infusion pumps …
2. メタノールおよびエチレングリコール中毒：マネージメントmethanol and ethylene glycol poisoning management [show details]
…bicarbonate via intravenous (IV) bolus for any patient with a pH below 7.3 . A maintenance infusion is then prepared by mixing approximately 133 meq of sodium bicarbonate in 1 liter of D5W. Infusion rates may …
3. Catheter-directed thrombolytic therapy in deep venous thrombosis of the lower extremity: Patient selection and administrationcatheter directed thrombolytic therapy in deep venous thrombosis of the lower extremity patient selection and administration [show details]
… After 24 to 48 hours of the infusion, most, if not all, of the thrombus should be dissolved. Infusions rarely extend beyond 48 hours. At that point, the infusion is discontinued,… We typically use intravenous (IV) unfractionated heparin for this purpose; further…
4. Anesthesia for cardiac surgery: General principlesanesthesia for cardiac surgery general principles [show details]
…prolonged infusion time required. General anesthesia may be maintained with a volatile anesthetic agent, a total intravenous anesthetic (TIVA) technique, or a combination of volatile and intravenous (IV) …
5. Coronavirus disease 2019 (COVID-19): Arrhythmias and conduction system diseasecoronavirus disease 2019 covid 19 arrhythmias and conduction system disease [show details]
…cardioversion/defibrillation Initial treatment with antiarrhythmic medications, with the exception of intravenous (IV) magnesium, is not indicated for hemodynamically unstable or pulseless patients. A full discussion … interventions to increase the heart rate, which include overdrive pacing and/or IV isoproterenol infusion. The management of other arrhythmias in the setting of COVID-19 infection is no different from …

Japanese Journal

イヌを用いたwhole body plethysmographyによる呼吸・循環器機能測定への静脈内持続投与の導入

中村康生,西勝英,今泉真和,馬成俊,佐々木一暁,天野秀人,山中洋泉,黒田裕二,片山誠一,直弘
日本トキシコロジー学会学術年会 37(0), 346-346, 2010
… 今回，我々は本方法にフリームービングによる静脈内持続静注を導入し，静脈内投与開始直後からの呼吸・循環器データの取得を試みた。 …
NAID 130007003202

Ｃｅｆａｚｏｌｉｎとセファマイシン系薬剤（Ｃｅｆｍｅｔａｚｏｌｅ，Ｃｅｆｏｘｉｔｉｎ）の静脈内持続静注時の吸収排せつおよび薬動力学的性状について

山作房之輔,鈴木康稔
ＣＨＥＭＯＴＨＥＲＡＰＹ 29(8), 857-864, 1981
健康成人男子志願者4名にcross overしてCefazolin, Cefmetazole, Cefoxitinそれぞれ2gを持続注入器を用い2時間で静脈内に注入し, bioassayとHPLCで血中濃度, 尿中濃度を測定した。2つの測定法による測定値はよく一致し, いずれの場合にも相関係数は0.988以上であった。bioassayで測定した注入終了時の平均最高血中濃度は, CFX44.9, C …
NAID 130004193451